Wird geladen...
Sustained Neurological Recovery after Stroke in Aged Rats Treated with a Novel Prostacyclin Analog
BACKGROUND AND PURPOSE: Targeting the prostacyclin/IP receptor to reduce stroke injury has been hindered by the lack of selective drugs. MRE-269 is the active metabolite of selexipag showing a very high selectivity toward the IP receptor. Selexipag has been recently approved for clinical use in pulm...
Gespeichert in:
| Veröffentlicht in: | Stroke |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5508605/ https://ncbi.nlm.nih.gov/pubmed/28588054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.117.016474 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|